Anaptysbio (ANAB) Amortizatization of Intangibles (2022 - 2023)
Anaptysbio (ANAB) posted Amortizatization of Intangibles of $3.0 million for Q3 2023, up 37.1% on a QoQ basis from $2.2 million in Q2 2023, and up 281.76% year-over-year from $784000.0 in Q3 2022.
Anaptysbio (ANAB) Amortizatization of Intangibles (2022 - 2023) Analysis & Trends
Anaptysbio's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $3.0 million for Q3 2023.
- Quarterly Amortizatization of Intangibles rose 281.76% year-over-year to $3.0 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $8.2 million (changed N/A YoY) and the FY2020 annual result came in at -$461000.0, down 117.51% from the prior year.
- Amortizatization of Intangibles was $3.0 million for Q3 2023 at Anaptysbio, up from $2.2 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.0 million in Q3 2023 and bottomed at -$161000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Anaptysbio | 1.54 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 2.99 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Sep 30, 2022 | 784,000.00 |
| Sep 30, 2022 | 784,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | -161,000.00 |
| Mar 31, 2022 | -161,000.00 |